nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxetine—ALB—type 1 diabetes mellitus	0.612	1	CbGaD
Fluoxetine—Red blood cell sedimentation rate increased—Ramipril—type 1 diabetes mellitus	0.0102	0.0414	CcSEcCtD
Fluoxetine—HTR2A—arteriole—type 1 diabetes mellitus	0.00953	0.157	CbGeAlD
Fluoxetine—ORM1—saliva—type 1 diabetes mellitus	0.00884	0.146	CbGeAlD
Fluoxetine—SLC6A2—autonomic nervous system—type 1 diabetes mellitus	0.00679	0.112	CbGeAlD
Fluoxetine—Cerebral ischaemia—Ramipril—type 1 diabetes mellitus	0.00566	0.0231	CcSEcCtD
Fluoxetine—Peripheral vascular disorder—Ramipril—type 1 diabetes mellitus	0.00558	0.0227	CcSEcCtD
Fluoxetine—Balance disorder—Ramipril—type 1 diabetes mellitus	0.00501	0.0204	CcSEcCtD
Fluoxetine—Inappropriate antidiuretic hormone secretion—Ramipril—type 1 diabetes mellitus	0.00471	0.0192	CcSEcCtD
Fluoxetine—Psoriasis—Ramipril—type 1 diabetes mellitus	0.00436	0.0177	CcSEcCtD
Fluoxetine—Parosmia—Ramipril—type 1 diabetes mellitus	0.00422	0.0172	CcSEcCtD
Fluoxetine—HTR2A—autonomic nervous system—type 1 diabetes mellitus	0.00408	0.0672	CbGeAlD
Fluoxetine—Neuralgia—Ramipril—type 1 diabetes mellitus	0.00394	0.016	CcSEcCtD
Fluoxetine—SLC6A2—nerve—type 1 diabetes mellitus	0.00382	0.0629	CbGeAlD
Fluoxetine—Ageusia—Ramipril—type 1 diabetes mellitus	0.00338	0.0138	CcSEcCtD
Fluoxetine—Liver injury—Ramipril—type 1 diabetes mellitus	0.00325	0.0132	CcSEcCtD
Fluoxetine—Disturbance in attention—Ramipril—type 1 diabetes mellitus	0.00316	0.0129	CcSEcCtD
Fluoxetine—Jaundice cholestatic—Ramipril—type 1 diabetes mellitus	0.00312	0.0127	CcSEcCtD
Fluoxetine—Cough increased—Ramipril—type 1 diabetes mellitus	0.00299	0.0122	CcSEcCtD
Fluoxetine—Glossitis—Ramipril—type 1 diabetes mellitus	0.00297	0.0121	CcSEcCtD
Fluoxetine—Drug interaction—Ramipril—type 1 diabetes mellitus	0.00295	0.012	CcSEcCtD
Fluoxetine—HTR2A—peripheral nervous system—type 1 diabetes mellitus	0.00294	0.0485	CbGeAlD
Fluoxetine—Leukocytosis—Ramipril—type 1 diabetes mellitus	0.00291	0.0119	CcSEcCtD
Fluoxetine—Vasculitis—Ramipril—type 1 diabetes mellitus	0.0028	0.0114	CcSEcCtD
Fluoxetine—Hepatocellular injury—Ramipril—type 1 diabetes mellitus	0.00274	0.0111	CcSEcCtD
Fluoxetine—Salivary hypersecretion—Ramipril—type 1 diabetes mellitus	0.00266	0.0108	CcSEcCtD
Fluoxetine—Blood urea increased—Ramipril—type 1 diabetes mellitus	0.00258	0.0105	CcSEcCtD
Fluoxetine—Neuropathy—Ramipril—type 1 diabetes mellitus	0.00257	0.0105	CcSEcCtD
Fluoxetine—Rash maculo-papular—Ramipril—type 1 diabetes mellitus	0.00249	0.0101	CcSEcCtD
Fluoxetine—Urine output increased—Ramipril—type 1 diabetes mellitus	0.00248	0.0101	CcSEcCtD
Fluoxetine—Gynaecomastia—Ramipril—type 1 diabetes mellitus	0.00245	0.00997	CcSEcCtD
Fluoxetine—Lightheadedness—Ramipril—type 1 diabetes mellitus	0.00245	0.00997	CcSEcCtD
Fluoxetine—Sleep disorder—Ramipril—type 1 diabetes mellitus	0.0023	0.00934	CcSEcCtD
Fluoxetine—HTR2A—nerve—type 1 diabetes mellitus	0.0023	0.0378	CbGeAlD
Fluoxetine—Polyuria—Ramipril—type 1 diabetes mellitus	0.00226	0.00921	CcSEcCtD
Fluoxetine—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.00224	0.00912	CcSEcCtD
Fluoxetine—Deafness—Ramipril—type 1 diabetes mellitus	0.00222	0.00904	CcSEcCtD
Fluoxetine—Vascular purpura—Ramipril—type 1 diabetes mellitus	0.00222	0.00904	CcSEcCtD
Fluoxetine—Hepatic failure—Ramipril—type 1 diabetes mellitus	0.00221	0.009	CcSEcCtD
Fluoxetine—Haemolytic anaemia—Ramipril—type 1 diabetes mellitus	0.0022	0.00896	CcSEcCtD
Fluoxetine—Libido decreased—Ramipril—type 1 diabetes mellitus	0.00214	0.00872	CcSEcCtD
Fluoxetine—Amnesia—Ramipril—type 1 diabetes mellitus	0.00212	0.00861	CcSEcCtD
Fluoxetine—Dermatitis exfoliative—Ramipril—type 1 diabetes mellitus	0.00211	0.00857	CcSEcCtD
Fluoxetine—Atrial fibrillation—Ramipril—type 1 diabetes mellitus	0.0021	0.00853	CcSEcCtD
Fluoxetine—Renal impairment—Ramipril—type 1 diabetes mellitus	0.00209	0.0085	CcSEcCtD
Fluoxetine—SIGMAR1—islet of Langerhans—type 1 diabetes mellitus	0.00209	0.0344	CbGeAlD
Fluoxetine—Purpura—Ramipril—type 1 diabetes mellitus	0.00206	0.00839	CcSEcCtD
Fluoxetine—Anaphylactoid reaction—Ramipril—type 1 diabetes mellitus	0.00205	0.00836	CcSEcCtD
Fluoxetine—Arthritis—Ramipril—type 1 diabetes mellitus	0.00204	0.00832	CcSEcCtD
Fluoxetine—Hypoglycaemia—Ramipril—type 1 diabetes mellitus	0.00204	0.00829	CcSEcCtD
Fluoxetine—Cerebrovascular accident—Ramipril—type 1 diabetes mellitus	0.00203	0.00825	CcSEcCtD
Fluoxetine—Hyponatraemia—Ramipril—type 1 diabetes mellitus	0.002	0.00812	CcSEcCtD
Fluoxetine—Disturbance in sexual arousal—Ramipril—type 1 diabetes mellitus	0.00197	0.00802	CcSEcCtD
Fluoxetine—Liver function test abnormal—Ramipril—type 1 diabetes mellitus	0.00183	0.00747	CcSEcCtD
Fluoxetine—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.00181	0.00739	CcSEcCtD
Fluoxetine—Breast disorder—Ramipril—type 1 diabetes mellitus	0.0018	0.00731	CcSEcCtD
Fluoxetine—Toxic epidermal necrolysis—Ramipril—type 1 diabetes mellitus	0.00179	0.00728	CcSEcCtD
Fluoxetine—Gastritis—Ramipril—type 1 diabetes mellitus	0.00176	0.00716	CcSEcCtD
Fluoxetine—Asthma—Ramipril—type 1 diabetes mellitus	0.00172	0.00699	CcSEcCtD
Fluoxetine—Dysphagia—Ramipril—type 1 diabetes mellitus	0.00172	0.00699	CcSEcCtD
Fluoxetine—Influenza—Ramipril—type 1 diabetes mellitus	0.00172	0.00699	CcSEcCtD
Fluoxetine—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.0017	0.00692	CcSEcCtD
Fluoxetine—Bronchospasm—Ramipril—type 1 diabetes mellitus	0.00169	0.00688	CcSEcCtD
Fluoxetine—Pancreatitis—Ramipril—type 1 diabetes mellitus	0.00168	0.00685	CcSEcCtD
Fluoxetine—SIGMAR1—nephron tubule—type 1 diabetes mellitus	0.00168	0.0277	CbGeAlD
Fluoxetine—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.00167	0.00681	CcSEcCtD
Fluoxetine—Sweating increased—Ramipril—type 1 diabetes mellitus	0.00167	0.00681	CcSEcCtD
Fluoxetine—Bronchitis—Ramipril—type 1 diabetes mellitus	0.00165	0.00672	CcSEcCtD
Fluoxetine—Pancytopenia—Ramipril—type 1 diabetes mellitus	0.00163	0.00664	CcSEcCtD
Fluoxetine—Upper respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.0016	0.0065	CcSEcCtD
Fluoxetine—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.00158	0.00644	CcSEcCtD
Fluoxetine—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.00157	0.00638	CcSEcCtD
Fluoxetine—Weight increased—Ramipril—type 1 diabetes mellitus	0.00156	0.00636	CcSEcCtD
Fluoxetine—Stevens-Johnson syndrome—Ramipril—type 1 diabetes mellitus	0.00152	0.00618	CcSEcCtD
Fluoxetine—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.00151	0.00614	CcSEcCtD
Fluoxetine—Renal failure—Ramipril—type 1 diabetes mellitus	0.00151	0.00613	CcSEcCtD
Fluoxetine—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.0015	0.00611	CcSEcCtD
Fluoxetine—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.0015	0.00611	CcSEcCtD
Fluoxetine—Stomatitis—Ramipril—type 1 diabetes mellitus	0.00149	0.00607	CcSEcCtD
Fluoxetine—Jaundice—Ramipril—type 1 diabetes mellitus	0.00149	0.00607	CcSEcCtD
Fluoxetine—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.00149	0.00606	CcSEcCtD
Fluoxetine—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.00149	0.00606	CcSEcCtD
Fluoxetine—Sweating—Ramipril—type 1 diabetes mellitus	0.00147	0.00597	CcSEcCtD
Fluoxetine—SIGMAR1—pancreas—type 1 diabetes mellitus	0.00147	0.0242	CbGeAlD
Fluoxetine—Epistaxis—Ramipril—type 1 diabetes mellitus	0.00144	0.00588	CcSEcCtD
Fluoxetine—Sinusitis—Ramipril—type 1 diabetes mellitus	0.00144	0.00585	CcSEcCtD
Fluoxetine—Hepatitis—Ramipril—type 1 diabetes mellitus	0.00137	0.00559	CcSEcCtD
Fluoxetine—CYP3A5—islet of Langerhans—type 1 diabetes mellitus	0.00137	0.0226	CbGeAlD
Fluoxetine—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.00135	0.00551	CcSEcCtD
Fluoxetine—Visual impairment—Ramipril—type 1 diabetes mellitus	0.00132	0.00539	CcSEcCtD
Fluoxetine—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.0013	0.00529	CcSEcCtD
Fluoxetine—Tinnitus—Ramipril—type 1 diabetes mellitus	0.00128	0.00522	CcSEcCtD
Fluoxetine—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.00123	0.005	CcSEcCtD
Fluoxetine—Alopecia—Ramipril—type 1 diabetes mellitus	0.00121	0.00494	CcSEcCtD
Fluoxetine—Mental disorder—Ramipril—type 1 diabetes mellitus	0.0012	0.0049	CcSEcCtD
Fluoxetine—Malnutrition—Ramipril—type 1 diabetes mellitus	0.0012	0.00487	CcSEcCtD
Fluoxetine—Tension—Ramipril—type 1 diabetes mellitus	0.00117	0.00478	CcSEcCtD
Fluoxetine—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.00117	0.00477	CcSEcCtD
Fluoxetine—Nervousness—Ramipril—type 1 diabetes mellitus	0.00116	0.00473	CcSEcCtD
Fluoxetine—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.00115	0.00468	CcSEcCtD
Fluoxetine—Tremor—Ramipril—type 1 diabetes mellitus	0.00112	0.00456	CcSEcCtD
Fluoxetine—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.00111	0.00452	CcSEcCtD
Fluoxetine—CYP3A5—nephron tubule—type 1 diabetes mellitus	0.0011	0.0182	CbGeAlD
Fluoxetine—Agitation—Ramipril—type 1 diabetes mellitus	0.0011	0.00448	CcSEcCtD
Fluoxetine—CYP2B6—nephron tubule—type 1 diabetes mellitus	0.0011	0.0181	CbGeAlD
Fluoxetine—Angioedema—Ramipril—type 1 diabetes mellitus	0.00109	0.00445	CcSEcCtD
Fluoxetine—Malaise—Ramipril—type 1 diabetes mellitus	0.00108	0.00439	CcSEcCtD
Fluoxetine—Vertigo—Ramipril—type 1 diabetes mellitus	0.00108	0.00438	CcSEcCtD
Fluoxetine—Syncope—Ramipril—type 1 diabetes mellitus	0.00107	0.00437	CcSEcCtD
Fluoxetine—Leukopenia—Ramipril—type 1 diabetes mellitus	0.00107	0.00436	CcSEcCtD
Fluoxetine—Palpitations—Ramipril—type 1 diabetes mellitus	0.00106	0.0043	CcSEcCtD
Fluoxetine—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.00105	0.00428	CcSEcCtD
Fluoxetine—Cough—Ramipril—type 1 diabetes mellitus	0.00104	0.00425	CcSEcCtD
Fluoxetine—Convulsion—Ramipril—type 1 diabetes mellitus	0.00104	0.00422	CcSEcCtD
Fluoxetine—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00102	0.00415	CcSEcCtD
Fluoxetine—Chest pain—Ramipril—type 1 diabetes mellitus	0.00102	0.00415	CcSEcCtD
Fluoxetine—Myalgia—Ramipril—type 1 diabetes mellitus	0.00102	0.00415	CcSEcCtD
Fluoxetine—Anxiety—Ramipril—type 1 diabetes mellitus	0.00102	0.00413	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.00101	0.00412	CcSEcCtD
Fluoxetine—Discomfort—Ramipril—type 1 diabetes mellitus	0.00101	0.0041	CcSEcCtD
Fluoxetine—Dry mouth—Ramipril—type 1 diabetes mellitus	0.000996	0.00406	CcSEcCtD
Fluoxetine—CYP2B6—cardiovascular system—type 1 diabetes mellitus	0.000986	0.0162	CbGeAlD
Fluoxetine—Confusional state—Ramipril—type 1 diabetes mellitus	0.000985	0.00401	CcSEcCtD
Fluoxetine—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.000977	0.00397	CcSEcCtD
Fluoxetine—CYP2C9—cardiovascular system—type 1 diabetes mellitus	0.000976	0.0161	CbGeAlD
Fluoxetine—CYP3A5—kidney—type 1 diabetes mellitus	0.00097	0.016	CbGeAlD
Fluoxetine—CYP2B6—kidney—type 1 diabetes mellitus	0.000965	0.0159	CbGeAlD
Fluoxetine—CYP3A5—pancreas—type 1 diabetes mellitus	0.000964	0.0159	CbGeAlD
Fluoxetine—Shock—Ramipril—type 1 diabetes mellitus	0.000961	0.00391	CcSEcCtD
Fluoxetine—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.000956	0.00389	CcSEcCtD
Fluoxetine—Tachycardia—Ramipril—type 1 diabetes mellitus	0.000953	0.00388	CcSEcCtD
Fluoxetine—HTR2A—retina—type 1 diabetes mellitus	0.000951	0.0157	CbGeAlD
Fluoxetine—Skin disorder—Ramipril—type 1 diabetes mellitus	0.000949	0.00386	CcSEcCtD
Fluoxetine—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.000944	0.00384	CcSEcCtD
Fluoxetine—Anorexia—Ramipril—type 1 diabetes mellitus	0.000931	0.00379	CcSEcCtD
Fluoxetine—Hypotension—Ramipril—type 1 diabetes mellitus	0.000913	0.00371	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00089	0.00362	CcSEcCtD
Fluoxetine—Insomnia—Ramipril—type 1 diabetes mellitus	0.000883	0.00359	CcSEcCtD
Fluoxetine—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.000877	0.00357	CcSEcCtD
Fluoxetine—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.000871	0.00354	CcSEcCtD
Fluoxetine—Somnolence—Ramipril—type 1 diabetes mellitus	0.000868	0.00353	CcSEcCtD
Fluoxetine—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.00086	0.0035	CcSEcCtD
Fluoxetine—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.000849	0.00346	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.000843	0.00343	CcSEcCtD
Fluoxetine—Fatigue—Ramipril—type 1 diabetes mellitus	0.000842	0.00343	CcSEcCtD
Fluoxetine—Constipation—Ramipril—type 1 diabetes mellitus	0.000835	0.0034	CcSEcCtD
Fluoxetine—CYP2B6—lymphoid tissue—type 1 diabetes mellitus	0.000828	0.0136	CbGeAlD
Fluoxetine—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.000805	0.00328	CcSEcCtD
Fluoxetine—HTR2A—cardiovascular system—type 1 diabetes mellitus	0.000804	0.0132	CbGeAlD
Fluoxetine—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.000799	0.00325	CcSEcCtD
Fluoxetine—HTR2A—kidney—type 1 diabetes mellitus	0.000787	0.013	CbGeAlD
Fluoxetine—Urticaria—Ramipril—type 1 diabetes mellitus	0.000776	0.00316	CcSEcCtD
Fluoxetine—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.000772	0.00314	CcSEcCtD
Fluoxetine—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.000772	0.00314	CcSEcCtD
Fluoxetine—ABCB1—islet of Langerhans—type 1 diabetes mellitus	0.000729	0.012	CbGeAlD
Fluoxetine—CYP3A4—kidney—type 1 diabetes mellitus	0.000728	0.012	CbGeAlD
Fluoxetine—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00072	0.00293	CcSEcCtD
Fluoxetine—CYP2D6—kidney—type 1 diabetes mellitus	0.000717	0.0118	CbGeAlD
Fluoxetine—Asthenia—Ramipril—type 1 diabetes mellitus	0.000701	0.00285	CcSEcCtD
Fluoxetine—Pruritus—Ramipril—type 1 diabetes mellitus	0.000691	0.00281	CcSEcCtD
Fluoxetine—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.000668	0.00272	CcSEcCtD
Fluoxetine—Dizziness—Ramipril—type 1 diabetes mellitus	0.000646	0.00263	CcSEcCtD
Fluoxetine—ABCB1—retina—type 1 diabetes mellitus	0.000623	0.0103	CbGeAlD
Fluoxetine—Vomiting—Ramipril—type 1 diabetes mellitus	0.000621	0.00253	CcSEcCtD
Fluoxetine—Rash—Ramipril—type 1 diabetes mellitus	0.000616	0.00251	CcSEcCtD
Fluoxetine—Dermatitis—Ramipril—type 1 diabetes mellitus	0.000615	0.0025	CcSEcCtD
Fluoxetine—Headache—Ramipril—type 1 diabetes mellitus	0.000612	0.00249	CcSEcCtD
Fluoxetine—ABCB1—nephron tubule—type 1 diabetes mellitus	0.000587	0.00966	CbGeAlD
Fluoxetine—Nausea—Ramipril—type 1 diabetes mellitus	0.00058	0.00236	CcSEcCtD
Fluoxetine—ABCB1—cardiovascular system—type 1 diabetes mellitus	0.000527	0.00868	CbGeAlD
Fluoxetine—ABCB1—kidney—type 1 diabetes mellitus	0.000516	0.00849	CbGeAlD
Fluoxetine—ABCB1—pancreas—type 1 diabetes mellitus	0.000512	0.00843	CbGeAlD
Fluoxetine—ABCB1—lymphoid tissue—type 1 diabetes mellitus	0.000443	0.00729	CbGeAlD
Fluoxetine—HTR2C—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	5.32e-05	0.000651	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR ligand binding—CCR5—type 1 diabetes mellitus	5.3e-05	0.000648	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	5.29e-05	0.000647	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—G6PC2—type 1 diabetes mellitus	5.23e-05	0.00064	CbGpPWpGaD
Fluoxetine—ABCB1—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	5.15e-05	0.00063	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	5.14e-05	0.000628	CbGpPWpGaD
Fluoxetine—HTR2A—SIDS Susceptibility Pathways—TNF—type 1 diabetes mellitus	5.11e-05	0.000625	CbGpPWpGaD
Fluoxetine—ABCB1—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	5.1e-05	0.000624	CbGpPWpGaD
Fluoxetine—ALB—Platelet activation, signaling and aggregation—IGF1—type 1 diabetes mellitus	4.96e-05	0.000607	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	4.91e-05	0.000601	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—type 1 diabetes mellitus	4.88e-05	0.000597	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—SST—type 1 diabetes mellitus	4.86e-05	0.000594	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	4.84e-05	0.000592	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—NOS1—type 1 diabetes mellitus	4.83e-05	0.000591	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—IAPP—type 1 diabetes mellitus	4.8e-05	0.000588	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—HBA2—type 1 diabetes mellitus	4.79e-05	0.000586	CbGpPWpGaD
Fluoxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 1 diabetes mellitus	4.78e-05	0.000585	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—GCG—type 1 diabetes mellitus	4.77e-05	0.000583	CbGpPWpGaD
Fluoxetine—ALB—Selenium Micronutrient Network—IL6—type 1 diabetes mellitus	4.68e-05	0.000573	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—SST—type 1 diabetes mellitus	4.64e-05	0.000568	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—ABCC8—type 1 diabetes mellitus	4.64e-05	0.000567	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	4.62e-05	0.000566	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	4.59e-05	0.000561	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—ABCC8—type 1 diabetes mellitus	4.53e-05	0.000555	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—PRKCQ—type 1 diabetes mellitus	4.53e-05	0.000554	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—G6PC2—type 1 diabetes mellitus	4.5e-05	0.000551	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	4.48e-05	0.000548	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	4.46e-05	0.000545	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	4.44e-05	0.000544	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—VAV1—type 1 diabetes mellitus	4.4e-05	0.000538	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—GCG—type 1 diabetes mellitus	4.33e-05	0.00053	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—HBA2—type 1 diabetes mellitus	4.3e-05	0.000526	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—SST—type 1 diabetes mellitus	4.22e-05	0.000516	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	4.2e-05	0.000514	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—HBA2—type 1 diabetes mellitus	4.2e-05	0.000513	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—GAL—type 1 diabetes mellitus	4.19e-05	0.000512	CbGpPWpGaD
Fluoxetine—SLC6A2—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	4.17e-05	0.000511	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	4.17e-05	0.00051	CbGpPWpGaD
Fluoxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 1 diabetes mellitus	4.15e-05	0.000508	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—GCG—type 1 diabetes mellitus	4.14e-05	0.000506	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CCL20—type 1 diabetes mellitus	4.14e-05	0.000506	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CCL11—type 1 diabetes mellitus	4.14e-05	0.000506	CbGpPWpGaD
Fluoxetine—HTR2A—SIDS Susceptibility Pathways—IL6—type 1 diabetes mellitus	4.12e-05	0.000504	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—VAV1—type 1 diabetes mellitus	4.05e-05	0.000495	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—G6PC2—type 1 diabetes mellitus	4.04e-05	0.000495	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	4.04e-05	0.000494	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	3.98e-05	0.000487	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—IGF2—type 1 diabetes mellitus	3.98e-05	0.000487	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—HBA2—type 1 diabetes mellitus	3.95e-05	0.000484	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—G6PC2—type 1 diabetes mellitus	3.95e-05	0.000483	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—HBA2—type 1 diabetes mellitus	3.92e-05	0.00048	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—ABCC8—type 1 diabetes mellitus	3.9e-05	0.000478	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CHRM2—type 1 diabetes mellitus	3.89e-05	0.000476	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	3.87e-05	0.000473	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	3.86e-05	0.000472	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	3.83e-05	0.000468	CbGpPWpGaD
Fluoxetine—ALB—Platelet activation, signaling and aggregation—IL2—type 1 diabetes mellitus	3.81e-05	0.000466	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—GCG—type 1 diabetes mellitus	3.76e-05	0.00046	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	3.76e-05	0.00046	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—G6PC2—type 1 diabetes mellitus	3.72e-05	0.000455	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—G6PC2—type 1 diabetes mellitus	3.69e-05	0.000451	CbGpPWpGaD
Fluoxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	3.67e-05	0.000449	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—KCNJ11—type 1 diabetes mellitus	3.67e-05	0.000449	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—GAL—type 1 diabetes mellitus	3.64e-05	0.000445	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	3.62e-05	0.000443	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CCL20—type 1 diabetes mellitus	3.59e-05	0.00044	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CCL11—type 1 diabetes mellitus	3.59e-05	0.00044	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—KCNJ11—type 1 diabetes mellitus	3.58e-05	0.000438	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—VAV1—type 1 diabetes mellitus	3.51e-05	0.00043	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—ABCC8—type 1 diabetes mellitus	3.51e-05	0.000429	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	3.5e-05	0.000429	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—ITPR3—type 1 diabetes mellitus	3.49e-05	0.000427	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	3.45e-05	0.000422	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—ABCC8—type 1 diabetes mellitus	3.42e-05	0.000419	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	3.4e-05	0.000416	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CHRM2—type 1 diabetes mellitus	3.38e-05	0.000413	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—IL2RA—type 1 diabetes mellitus	3.35e-05	0.00041	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—HBA2—type 1 diabetes mellitus	3.35e-05	0.00041	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—SH2B3—type 1 diabetes mellitus	3.29e-05	0.000402	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—IAPP—type 1 diabetes mellitus	3.27e-05	0.0004	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—APOC3—type 1 diabetes mellitus	3.27e-05	0.0004	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—ABCC8—type 1 diabetes mellitus	3.22e-05	0.000394	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—ABCC8—type 1 diabetes mellitus	3.2e-05	0.000391	CbGpPWpGaD
Fluoxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	3.19e-05	0.00039	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—G6PC2—type 1 diabetes mellitus	3.15e-05	0.000385	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—CCR5—type 1 diabetes mellitus	3.13e-05	0.000383	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—ITPR3—type 1 diabetes mellitus	3.09e-05	0.000379	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—KCNJ11—type 1 diabetes mellitus	3.09e-05	0.000378	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	3.08e-05	0.000377	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	3.03e-05	0.000371	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—ITPR3—type 1 diabetes mellitus	3.03e-05	0.00037	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	2.99e-05	0.000366	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	2.95e-05	0.000361	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—HBA1—type 1 diabetes mellitus	2.91e-05	0.000356	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—APOC3—type 1 diabetes mellitus	2.89e-05	0.000354	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—NOS2—type 1 diabetes mellitus	2.88e-05	0.000353	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	2.87e-05	0.000351	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—SST—type 1 diabetes mellitus	2.87e-05	0.000351	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—ADRB1—type 1 diabetes mellitus	2.86e-05	0.000349	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	2.86e-05	0.000349	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—HBA1—type 1 diabetes mellitus	2.85e-05	0.000348	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—GSTT1—type 1 diabetes mellitus	2.84e-05	0.000348	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—APOC3—type 1 diabetes mellitus	2.84e-05	0.000347	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—IAPP—type 1 diabetes mellitus	2.84e-05	0.000347	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—APOC3—type 1 diabetes mellitus	2.83e-05	0.000346	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—GSTT1—type 1 diabetes mellitus	2.78e-05	0.00034	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—KCNJ11—type 1 diabetes mellitus	2.77e-05	0.000339	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	2.73e-05	0.000334	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—ABCC8—type 1 diabetes mellitus	2.73e-05	0.000334	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—CCR5—type 1 diabetes mellitus	2.72e-05	0.000332	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—KCNJ11—type 1 diabetes mellitus	2.7e-05	0.000331	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	2.68e-05	0.000328	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—ITPR3—type 1 diabetes mellitus	2.61e-05	0.000319	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	2.59e-05	0.000316	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—GCG—type 1 diabetes mellitus	2.56e-05	0.000313	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—IGF1—type 1 diabetes mellitus	2.56e-05	0.000313	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—KCNJ11—type 1 diabetes mellitus	2.55e-05	0.000312	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—KCNJ11—type 1 diabetes mellitus	2.53e-05	0.000309	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—SST—type 1 diabetes mellitus	2.49e-05	0.000305	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	2.48e-05	0.000303	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	2.46e-05	0.000301	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—HBA1—type 1 diabetes mellitus	2.45e-05	0.0003	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—APOC3—type 1 diabetes mellitus	2.44e-05	0.000298	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	2.43e-05	0.000297	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—GSTT1—type 1 diabetes mellitus	2.39e-05	0.000293	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—VAV1—type 1 diabetes mellitus	2.39e-05	0.000292	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CXCL10—type 1 diabetes mellitus	2.38e-05	0.000292	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—ITPR3—type 1 diabetes mellitus	2.34e-05	0.000286	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—NOS3—type 1 diabetes mellitus	2.32e-05	0.000284	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—ITPR3—type 1 diabetes mellitus	2.28e-05	0.000279	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—GCG—type 1 diabetes mellitus	2.27e-05	0.000277	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—GCG—type 1 diabetes mellitus	2.22e-05	0.000272	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—GCG—type 1 diabetes mellitus	2.21e-05	0.000271	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—HBA1—type 1 diabetes mellitus	2.2e-05	0.000269	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—APOC3—type 1 diabetes mellitus	2.19e-05	0.000268	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—TYK2—type 1 diabetes mellitus	2.17e-05	0.000266	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—IGF2—type 1 diabetes mellitus	2.16e-05	0.000265	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—KCNJ11—type 1 diabetes mellitus	2.16e-05	0.000264	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—ITPR3—type 1 diabetes mellitus	2.15e-05	0.000263	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—HBA1—type 1 diabetes mellitus	2.15e-05	0.000263	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—GSTT1—type 1 diabetes mellitus	2.15e-05	0.000263	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	2.14e-05	0.000261	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—APOC3—type 1 diabetes mellitus	2.14e-05	0.000261	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—ITPR3—type 1 diabetes mellitus	2.13e-05	0.000261	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	2.11e-05	0.000258	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—GSTT1—type 1 diabetes mellitus	2.1e-05	0.000257	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CD86—type 1 diabetes mellitus	2.08e-05	0.000255	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—VAV1—type 1 diabetes mellitus	2.08e-05	0.000254	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	2.07e-05	0.000253	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—HBA1—type 1 diabetes mellitus	2.02e-05	0.000248	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—APOC3—type 1 diabetes mellitus	2.01e-05	0.000246	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—HBA1—type 1 diabetes mellitus	2.01e-05	0.000246	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—APOC3—type 1 diabetes mellitus	1.99e-05	0.000244	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.99e-05	0.000244	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.98e-05	0.000242	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.98e-05	0.000242	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—GSTT1—type 1 diabetes mellitus	1.98e-05	0.000242	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—IL2—type 1 diabetes mellitus	1.96e-05	0.00024	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—GSTT1—type 1 diabetes mellitus	1.96e-05	0.00024	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—CAT—type 1 diabetes mellitus	1.92e-05	0.000235	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—GCG—type 1 diabetes mellitus	1.91e-05	0.000233	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.89e-05	0.000231	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.88e-05	0.00023	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.88e-05	0.00023	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—CAT—type 1 diabetes mellitus	1.87e-05	0.000229	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.85e-05	0.000226	CbGpPWpGaD
Fluoxetine—ABCB1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	1.84e-05	0.000225	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—ITPR3—type 1 diabetes mellitus	1.82e-05	0.000223	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.82e-05	0.000223	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CD86—type 1 diabetes mellitus	1.81e-05	0.000221	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.81e-05	0.000221	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.81e-05	0.000221	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.73e-05	0.000212	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.72e-05	0.00021	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—HBA1—type 1 diabetes mellitus	1.72e-05	0.00021	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—GCG—type 1 diabetes mellitus	1.71e-05	0.000209	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—APOC3—type 1 diabetes mellitus	1.7e-05	0.000209	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—GSTT1—type 1 diabetes mellitus	1.67e-05	0.000205	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—GCG—type 1 diabetes mellitus	1.67e-05	0.000204	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	1.67e-05	0.000204	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.63e-05	0.0002	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—CAT—type 1 diabetes mellitus	1.61e-05	0.000197	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.61e-05	0.000196	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.58e-05	0.000194	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	1.57e-05	0.000193	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.57e-05	0.000192	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—GCG—type 1 diabetes mellitus	1.56e-05	0.000191	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.54e-05	0.000189	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CD80—type 1 diabetes mellitus	1.52e-05	0.000186	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—CAT—type 1 diabetes mellitus	1.45e-05	0.000177	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—INS—type 1 diabetes mellitus	1.44e-05	0.000176	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	1.41e-05	0.000173	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	1.41e-05	0.000172	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.39e-05	0.00017	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.38e-05	0.000169	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—GCG—type 1 diabetes mellitus	1.33e-05	0.000163	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	1.33e-05	0.000163	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	1.32e-05	0.000162	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—CAT—type 1 diabetes mellitus	1.32e-05	0.000162	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CD80—type 1 diabetes mellitus	1.32e-05	0.000162	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	1.32e-05	0.000161	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	1.29e-05	0.000158	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.28e-05	0.000157	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—INS—type 1 diabetes mellitus	1.27e-05	0.000156	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.26e-05	0.000154	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—INS—type 1 diabetes mellitus	1.25e-05	0.000153	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—INS—type 1 diabetes mellitus	1.24e-05	0.000152	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.21e-05	0.000148	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.2e-05	0.000147	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—ALB—type 1 diabetes mellitus	1.17e-05	0.000143	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—ALB—type 1 diabetes mellitus	1.14e-05	0.00014	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—CAT—type 1 diabetes mellitus	1.13e-05	0.000138	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—NOS3—type 1 diabetes mellitus	1.12e-05	0.000137	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.11e-05	0.000136	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.09e-05	0.000134	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—NOS3—type 1 diabetes mellitus	1.09e-05	0.000133	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—INS—type 1 diabetes mellitus	1.07e-05	0.000131	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.07e-05	0.000131	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—IL2—type 1 diabetes mellitus	1.07e-05	0.000131	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.06e-05	0.00013	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	1.03e-05	0.000126	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—INS—type 1 diabetes mellitus	9.62e-06	0.000118	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—NOS3—type 1 diabetes mellitus	9.4e-06	0.000115	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—INS—type 1 diabetes mellitus	9.39e-06	0.000115	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	9.29e-06	0.000114	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—IL2—type 1 diabetes mellitus	9.28e-06	0.000113	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	9.23e-06	0.000113	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—STAT3—type 1 diabetes mellitus	8.99e-06	0.00011	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	8.85e-06	0.000108	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—ALB—type 1 diabetes mellitus	8.82e-06	0.000108	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—INS—type 1 diabetes mellitus	8.77e-06	0.000107	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	8.71e-06	0.000107	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	8.61e-06	0.000105	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—NOS3—type 1 diabetes mellitus	8.44e-06	0.000103	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	8.23e-06	0.000101	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—EGFR—type 1 diabetes mellitus	8.17e-06	9.99e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	8.11e-06	9.92e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—ALB—type 1 diabetes mellitus	8.04e-06	9.84e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	7.81e-06	9.55e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	7.76e-06	9.49e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—NOS3—type 1 diabetes mellitus	7.69e-06	9.41e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—INS—type 1 diabetes mellitus	7.49e-06	9.17e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.09e-06	8.68e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—ALB—type 1 diabetes mellitus	6.87e-06	8.41e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—NOS3—type 1 diabetes mellitus	6.57e-06	8.04e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—IL6—type 1 diabetes mellitus	6.28e-06	7.68e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	5.78e-06	7.08e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—IL6—type 1 diabetes mellitus	5.45e-06	6.67e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	5.3e-06	6.49e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	5.07e-06	6.21e-05	CbGpPWpGaD
